Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Environment Water Monitoring topic
No spam. Unsubscribe anytime.
FDA-led dye study to trace Norwalk WWTP effluent into Norwalk River and Harbor
Summary
Staff told the Norwalk Water Pollution Control meeting that the FDA and aquaculture team will introduce a reddish tracer dye into the wastewater treatment plant effluent to map how discharge moves through the Norwalk River and into the harbor over several days; the study is science-based, not a WPCA program, and staff said the team issued public notice and will collect samples from boats.
At its May 18 regular meeting, the Norwalk Water Pollution Control body was briefed on an upcoming dye-tracing study led by the U.S. Food and Drug Administration and an aquaculture partner to evaluate the wastewater treatment plant’s effluent pathways.
Staff said crews delivered equipment and that the team will introduce a reddish tracer into plant effluent the morning after the meeting and then sample the plume over several days to understand where discharge travels and at what concentrations. A staff member emphasized the study is an FDA/aquaculture scientific study rather than a WPCA program.
Board members asked whether the public had been notified; staff said the study team issued a public notice and the city amplified that notice via its social media channels. Staff cautioned that concentrated patches of dye may be visible initially (described as reddish, comparable to a concentrated iced-tea color) but will dilute quickly and likely be invisible to most observers as it disperses. The study team will have boats on the water to monitor and collect grab samples at multiple locations.
Members discussed the study’s purpose and potential implications for shellfish beds: staff said FDA/aquaculture will compare the dye distribution with known sensitive areas and shellfish beds and analyze concentrations; one board member recalled prior local tests that showed plant effluent was cleaner than some receiving waters. Several members noted Norwalk’s active oyster and shellfish beds and expressed hope the study could support future reopening or expanded shellfishing areas if results are favorable.
Staff also reported that the FDA/aquaculture team toured the treatment plant and provided early positive feedback on the appearance of the plant effluent. The study’s findings and any agency conclusions will be determined by the FDA/aquaculture analysis and reporting timeline.
The board did not take formal action during the meeting because there was no quorum; staff encouraged members of the public who have questions to consult the public notices and the city’s posted updates.
